BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38543157)

  • 1. The Effect of Heparin and Other Exogenous Glycosaminoglycans (GAGs) in Reducing IL-1β-Induced Pro-Inflammatory Cytokine IL-8 and IL-6 mRNA Expression and the Potential Role for Reducing Inflammation.
    Jafri M; Li L; Liang B; Luo M
    Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfated glycosaminoglycans modify growth factor-induced neurite outgrowth in PC12 cells.
    Damon DH; D'Amore PA; Wagner JA
    J Cell Physiol; 1988 May; 135(2):293-300. PubMed ID: 2967302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte cell surface glycosaminoglycans positively modulate IL-4-induced differentiation toward dendritic cells.
    den Dekker E; Grefte S; Huijs T; ten Dam GB; Versteeg EM; van den Berk LC; Bladergroen BA; van Kuppevelt TH; Figdor CG; Torensma R
    J Immunol; 2008 Mar; 180(6):3680-8. PubMed ID: 18322173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoenzymatic Synthesis of Glycosaminoglycans.
    Zhang X; Lin L; Huang H; Linhardt RJ
    Acc Chem Res; 2020 Feb; 53(2):335-346. PubMed ID: 31714740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.
    Harris N; Kogan FY; Il'kova G; Juhas S; Lahmy O; Gregor YI; Koppel J; Zhuk R; Gregor P
    Biochim Biophys Acta; 2014 Jan; 1840(1):245-54. PubMed ID: 24060749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondroitin sulfate inhibits secretion of TNF and CXCL8 from human mast cells stimulated by IL-33.
    Gross AR; Theoharides TC
    Biofactors; 2019 Jan; 45(1):49-61. PubMed ID: 30521103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.
    Kuschert GS; Coulin F; Power CA; Proudfoot AE; Hubbard RE; Hoogewerf AJ; Wells TN
    Biochemistry; 1999 Sep; 38(39):12959-68. PubMed ID: 10504268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosaminoglycan Quality Control by Monosaccharide Analysis.
    Zhang Y; Ma X; Zhang L
    Methods Mol Biol; 2022; 2303():297-306. PubMed ID: 34626388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of macrophage glycosaminoglycans in the cellular catabolism of oxidized LDL by macrophages.
    Kaplan M; Williams KJ; Mandel H; Aviram M
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):542-53. PubMed ID: 9555859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosaminoglycans bind human IL-27 and regulate its activity.
    Cavé MC; Maillard S; Hildenbrand K; Mamelonet C; Feige MJ; Devergne O
    Eur J Immunol; 2020 Oct; 50(10):1484-1499. PubMed ID: 32483835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Source-induced fragmentation of heparin, heparan, and galactosaminoglycans and application.
    Hu P; Fang L; Chess EK
    Anal Chem; 2009 Mar; 81(6):2332-43. PubMed ID: 19228018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosaminoglycans enhance human leukemic cell growth in vitro.
    Maurer AM; Han ZC; Dhermy D; Brière J
    Leuk Res; 1994 Nov; 18(11):837-42. PubMed ID: 7967710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
    Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
    Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical characterization of glycosaminoglycan-IL-7 interactions using SPR.
    Zhang F; Liang X; Pu D; George KI; Holland PJ; Walsh ST; Linhardt RJ
    Biochimie; 2012 Jan; 94(1):242-9. PubMed ID: 22085638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of Superficial Zone Protein/Lubricin/PRG4 by Transforming Growth Factor-β in Superficial Zone Articular Chondrocytes and Modulation by Glycosaminoglycans.
    Cuellar A; Reddi AH
    Tissue Eng Part A; 2015 Jul; 21(13-14):1973-81. PubMed ID: 25398329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease.
    Souza-Fernandes AB; Pelosi P; Rocco PR
    Crit Care; 2006; 10(6):237. PubMed ID: 17118216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosaminoglycans increase levels of free and bioactive IGF-I in vitro.
    Møller AV; Jørgensen SP; Chen JW; Larnkjaer A; Ledet T; Flyvbjerg A; Frystyk J
    Eur J Endocrinol; 2006 Aug; 155(2):297-305. PubMed ID: 16868144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
    Kosir MA; Quinn CC; Wang W; Tromp G
    J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection.
    Hallak LK; Collins PL; Knudson W; Peeples ME
    Virology; 2000 Jun; 271(2):264-75. PubMed ID: 10860881
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.